HIV-1 Vpr Enhances Viral Burden by Facilitating Infection of Tissue Macrophages but Not Nondividing CD4+ T Cells

Journal of Experimental Medicine - Tập 194 Số 10 - Trang 1407-1419 - 2001
Daniel A. Eckstein1,2, Michael P. Sherman1,3, Michael L. Penn1,2, Peggy S. Chin1, Carlos M. C. de Noronha1, Warner C. Greene1,2,3,4, Mark A. Goldsmith1,2,3
11Gladstone Institute of Virology and Immunology, University of California San Francisco, San Francisco, CA 94141
22School of Medicine, University of California San Francisco, San Francisco, CA 94141
33Department of Medicine, University of California San Francisco, San Francisco, CA 94141
44Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA 94141

Tóm tắt

Prior experiments in explants of human lymphoid tissue have demonstrated that human immunodeficiency virus type 1 (HIV-1) productively infects diverse cellular targets including T cells and tissue macrophages. We sought to determine the specific contribution of macrophages and T cells to the overall viral burden within lymphoid tissue. To block infection of macrophages selectively while preserving infection of T cells, we used viruses deficient for viral protein R (Vpr) that exhibit profound replication defects in nondividing cells in vitro. We inoculated tonsil histocultures with matched pairs of congenic viruses that differed only by the presence of a wild-type or truncated vpr gene. Although these viruses exhibited no reduction in the infection or depletion of T cells, the ability of the Vpr-deficient R5 virus to infect tissue macrophages was severely impaired compared with matched wild-type R5 virus. Interestingly, the Vpr-deficient R5 virus also exhibited a 50% reduction in overall virus replication compared with its wild-type counterpart despite the fact that macrophages represent a small fraction of the potential targets of HIV-1 infection in these tissues. Collectively, these data highlight the importance of tissue macrophages in local viral burden and further implicate roles for CC chemokine receptor 5, macrophages, and Vpr in the life cycle and pathogenesis of HIV-1.

Từ khóa


Tài liệu tham khảo

1992, Proc. Natl. Acad. Sci. USA., 89, 6580, 10.1073/pnas.89.14.6580

1994, Virology., 200, 623, 10.1006/viro.1994.1225

1994, Proc. Natl. Acad. Sci. USA., 91, 7311, 10.1073/pnas.91.15.7311

1995, Virology., 206, 935, 10.1006/viro.1995.1016

1998, EMBO J., 17, 909, 10.1093/emboj/17.4.909

1998, Genes Dev., 12, 175, 10.1101/gad.12.2.175

1996, J. Virol., 70, 2324, 10.1128/jvi.70.4.2324-2331.1996

1998, Nat. Med., 4, 65, 10.1038/nm0198-065

1995, J. Virol., 69, 6705, 10.1128/jvi.69.11.6705-6711.1995

1995, J. Virol., 69, 6304, 10.1128/jvi.69.10.6304-6313.1995

1995, J. Virol., 69, 6859, 10.1128/jvi.69.11.6859-6864.1995

1990, J. Acquir. Immune Defic. Syndr., 3, 11

1990, J. Virol., 64, 3097, 10.1128/jvi.64.6.3097-3099.1990

1993, J. Virol., 67, 7229, 10.1128/jvi.67.12.7229-7237.1993

1990, AIDS Res. Hum. Retrovir., 6, 1265, 10.1089/aid.1990.6.1265

1998, J. Virol., 72, 6937, 10.1128/JVI.72.8.6937-6943.1998

1994, J. Virol., 68, 510, 10.1128/jvi.68.1.510-516.1994

1974, J. Virol., 14, 531, 10.1128/jvi.14.3.531-546.1974

1993, Nature., 365, 666, 10.1038/365666a0

1996, J. Virol., 70, 1027, 10.1128/jvi.70.2.1027-1032.1996

1994, Proc. Natl. Acad. Sci. USA., 91, 6992, 10.1073/pnas.91.15.6992

1997, Proc. Natl. Acad. Sci. USA., 94, 9825, 10.1073/pnas.94.18.9825

2000, J. Virol., 74, 7119, 10.1128/JVI.74.15.7119-7126.2000

2001, Mol. Cell., 7, 1025, 10.1016/S1097-2765(01)00240-4

2000, Cell., 101, 173, 10.1016/S0092-8674(00)80828-4

1997, J. Virol., 71, 5382, 10.1128/jvi.71.7.5382-5390.1997

1998, J. Biol. Chem., 273, 13347, 10.1074/jbc.273.21.13347

1998, J. Cell Biol., 143, 875, 10.1083/jcb.143.4.875

2001, J. Virol., 75, 1522, 10.1128/JVI.75.3.1522-1532.2001

1999, J. Virol., 73, 4101, 10.1128/JVI.73.5.4101-4109.1999

1998, J. Mol. Biol., 284, 915, 10.1006/jmbi.1998.2206

1998, J. Virol., 72, 4686, 10.1128/JVI.72.6.4686-4693.1998

1997, J. Virol., 71, 5579, 10.1128/jvi.71.7.5579-5592.1997

1999, Proc. Natl. Acad. Sci. USA., 96, 12039, 10.1073/pnas.96.21.12039

2000, J. Virol., 74, 3105, 10.1128/JVI.74.7.3105-3111.2000

2000, J. Immunol., 165, 3293, 10.4049/jimmunol.165.6.3293

1998, Science., 281, 266, 10.1126/science.281.5374.266

1997, Nat. Med., 3, 1117, 10.1038/nm1097-1117

1998, J. Exp. Med., 187, 403, 10.1084/jem.187.3.403

1997, AIDS Res. Hum. Retrovir., 13, 461, 10.1089/aid.1997.13.461

1999, Proc. Natl. Acad. Sci. USA., 96, 663, 10.1073/pnas.96.2.663

2000, J. Virol., 74, 9594, 10.1128/JVI.74.20.9594-9600.2000

2000, J. Virol., 74, 5347, 10.1128/JVI.74.11.5347-5351.2000

2000, J. Virol., 74, 184, 10.1128/JVI.74.1.184-192.2000

1995, Virology., 213, 70, 10.1006/viro.1995.1547

1994, AIDS Res. Hum. Retrovir., 10, 343, 10.1089/aid.1994.10.343

2001, Immunity., 15, 671, 10.1016/S1074-7613(01)00217-5

1995, J. Virol., 69, 7032, 10.1128/jvi.69.11.7032-7044.1995

1996, EMBO J., 15, 6155, 10.1002/j.1460-2075.1996.tb01003.x

1999, Science., 286, 1353, 10.1126/science.286.5443.1353

1999, J. Virol., 73, 6430, 10.1128/JVI.73.8.6430-6435.1999

2000, Proc. Natl. Acad. Sci. USA., 97, 1269, 10.1073/pnas.97.3.1269

1995, Proc. Natl. Acad. Sci. USA., 92, 11889, 10.1073/pnas.92.25.11889

1989, J. Virol., 63, 3205, 10.1128/jvi.63.7.3205-3208.1989

1990, Proc. Natl. Acad. Sci. USA., 87, 8080, 10.1073/pnas.87.20.8080

1999, Virology., 253, 170, 10.1006/viro.1998.9482

1991, Proc. Natl. Acad. Sci. USA., 88, 9838, 10.1073/pnas.88.21.9838

1999, Nat. Med., 5, 997, 10.1038/12433

1999, J. Exp. Med., 189, 1545, 10.1084/jem.189.10.1545

2001, Proc. Natl. Acad. Sci. USA., 98, 658, 10.1073/pnas.98.2.658

1995, Nature., 373, 123, 10.1038/373123a0

1995, Nature., 373, 117, 10.1038/373117a0

1996, Science., 271, 1582, 10.1126/science.271.5255.1582

1997, Nature., 387, 188, 10.1038/387188a0

1997, Science., 278, 1291, 10.1126/science.278.5341.1291

1997, Science., 278, 1295, 10.1126/science.278.5341.1295

1997, Proc. Natl. Acad. Sci. USA., 94, 13193, 10.1073/pnas.94.24.13193

2000, Nat. Med., 6, 757, 10.1038/77481